close

Enter

Log in using OpenID

Global Immune Repertoire Sequencing Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Immune repertoire sequencing market is forecasted to value over US$ 175 Million by 2029 end and a register a CAGR of over 7.5% from 2019 to 2029. Immune repertoire sequencing is vastly utilized in biomarker discovery. It's used to improve the cost-e
Global Immune Repertoire Sequencing Market Global Trends, Market Share,
Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Immune repertoire sequencing market is forecasted to value over US$ 175 Million by
2029 end and a register a CAGR of over 7.5% from 2019 to 2029.
Immune repertoire sequencing is vastly utilized in biomarker discovery. It's used to
improve the cost-effectiveness and success rate of rational drug development.
Immune repertoire sequencing is significant in understanding the human body’s
auto-defense technique against outer agents.
Increasing research and development have been stimulating the growth of the
market. According to the latest research, Immune repertoire sequencing can be used
to detect systemic sclerosis-related pulmonary hypertension (SSc-PAH). Hence,
increasing research is fueling the growth of the market. Rising prevalence of cancer
and other infectious diseases is also boosting the growth of the market. Prominent
players launching innovative products are also boosting the growth of the market.
The innovation of products has led to extensive use of clinical requirements for
patients which fueled the growth of the market.
The immune repertoire sequencing market is segmented by component, by
application, and by the end user. By component, the market is bifurcated into assay
kits and software & services. The assay kits are further divided into TCR Kits and BCR
Kits. Assay kit is expected to hold a major share of the market in the forecast period.
TCR Kits control the adaptive immune system's capability to create a vast collection
of T-cell receptors. Multiple companies are looking for merging in order to develop
repertoire sequencing kits for immunotherapy response of a specific kind. For
example, MIODx and DiaCarta collaborated together to develop MIODX's
ClonoMapto predict the response of the patient to immunotherapy. Such kits will
help in providing an accurate understanding of response and behavior of adaptive
immunity.
On the basis of software & services, the market is bifurcated into analytical software,
sequencing services, and data analysis services.
The end users of the market are infectious diseases, vaccine development, cancer
immunotherapy, autoimmune disease, and transplant rejection & tolerance. Rising
infectious diseases and research regarding cancer immunotherapy is expected to
drive the growth of the market.
The challenges regarding distinguishing biological variations from errors are expected
to hinder the growth of the market. Limitation in providing accurate data has
resulted in unsatisfactory performance from bioinformatics techniques like high
throughput screening which has put further restrains regarding the growth of the
market.
In terms of region, North America is expected to hold a vast share of the market.
Rising demand for immunotherapy for other infectious diseases and cancer is the key
reason behind the growth of the market in the region. According to the U.S National
Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer are expected
to be diagnosed in the U.S. Immune repertoire sequencing plays a vital role in
fighting cancer and other infectious diseases.
Europe is expected to achieve the highest growth in the forecast period. The
increased funding by the government alongside rising healthcare expenditure is
expected to expand the size of the market in the region. Asia-Pacific region is also
predicted to show immense growth of the market in the coming years. Rising
adoption of immune repertoire sequencing in developing nations is expected to spur
the size of the market. Latest developments by developing countries like Japan for
the integration of advanced technology are expected to stimulate the size of the
market.
Prominent players of the market are CD Genomics, Atreca Inc., ArcherDX, Illumina
Inc., Roche Holding AG, Adaptive Biotechnologies and ThermoFisher Scientific Inc.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=256&page=requestsample
Immune Repertoire Sequencing Market Segmentation:
By Component
Assay Kits
 TCR Kits
 BCR Kits
Software & Services
 Analytical Software
 Sequencing Services
 Data Analysis Services
By Application







Biomaker Discovery
Infectious Diseases
Vaccine development and efficacy
Cancer Immunotherapy
Autoimmune Disease
Transplant rejection and Tolerance
Others
By Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=256&license=single
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the immune repertoire sequencing
market based on the components, end users and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
3
File Size
20 KB
Tags
healthcare, health
1/--pages
Report inappropriate content